Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 121,330 | 68,830 | 66,338 | 99,248 | 37,408 |
| Marketable Securities | 26,004 | 0 | 19,760 | N/A | 0 |
| Receivables | 26,908 | 23,991 | 20,987 | 11,454 | 45,679 |
| Other current assets | 0 | 0 | 0 | 0 | 2,033 |
| TOTAL | $187,366 | $103,213 | $117,009 | $116,518 | $104,118 |
| Non-Current Assets | |||||
| PPE Net | 2,331 | 2,310 | 2,664 | 2,624 | 1,536 |
| Investments And Advances | N/A | 362 | 344 | 406 | 413 |
| Intangibles | 9,704 | 10,349 | 10,080 | 10,279 | 11,096 |
| Other Non-Current Assets | 3,234 | 3,287 | 0 | 0 | 0 |
| TOTAL | $15,269 | $16,307 | $13,087 | $13,309 | $13,045 |
| Total Assets | $202,635 | $119,520 | $130,096 | $129,827 | $117,163 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,697 | 3,349 | 3,856 | 5,486 | 3,114 |
| Accrued Expenses | 8,361 | 11,274 | 713 | 8,388 | 6,542 |
| TOTAL | $16,822 | $22,636 | $26,555 | $20,470 | $34,854 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 306 | 6,575 | 10,727 | 5,732 | 23,225 |
| TOTAL | $51,790 | $75,164 | $76,830 | $97,850 | $69,963 |
| Total Liabilities | $68,612 | $97,800 | $103,385 | $118,320 | $104,818 |
| Shareholders' Equity | |||||
| Common Shares | 10,288 | 7,570 | 6,523 | 6,059 | 5,676 |
| Retained earnings | -474,044 | -388,046 | -318,601 | -300,923 | -251,053 |
| Other shareholders' equity | -11,781 | 75,261 | 58,188 | 50,580 | 41,131 |
| TOTAL | $134,023 | $21,720 | $26,712 | $11,507 | $12,346 |
| Total Liabilities And Equity | $202,635 | $119,520 | $130,096 | $129,827 | $117,163 |